Omalizumab in chronic inducible urticaria: a real-life study of
efficacy, safety, predictors of treatment outcome and time to response
- Miao Yu,
- Dorothea Terhorst-Molawi,
- Sabine Altrichter,
- Tomasz Hawro,
- Yu-di Chen,
- Bo Liu,
- Xiaoting Song,
- Marcus Maurer,
- Zuotao Zhao
Dorothea Terhorst-Molawi
Charité Universitätsmedizin Berlin
Author ProfileMay 2021Published in Clinical & Experimental Allergy volume 51 issue 5 on pages 730-734. 10.1111/cea.13838